Inventor

Koichi Fujimoto

Inventor

Tokyo, JP

Overview

23→

Patents

1984–2006

Patent span

Chemistry

Primary field (CPC C)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds48%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%

Y02PClimate change mitigation technologies in the production or processing of goods8%

A61KPreparations for medical, dental or toiletry purposes6%

C07CAcyclic or carbocyclic compounds2%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%

PatentTitleYear

7,030,138'Benzamidine derivatives'2006 6,555,556'Benzamidine derivatives'2003 6,117,893'Heterocyclic compounds having anti-diabetic activity and their use'2000 5,977,365'Heterocyclic compound having anti-diabetic activity'1999 5,972,959'Oxime derivatives, their preparation and their therapeutic use'1999 5,962,470'Heterocyclic compounds having anti-diabetic activity and their use'1999 5,886,014'Benzimidazole derivatives, their preparation and their therapeutic use'1999 5,843,983'Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use'1998 5,834,501'Heterocyclic compounds having anti-diabetic activity and their use'1998 5,780,490'Oxime derivatives, their preparation and their therapeutic use'1998 5,739,345'Intermediate compounds in the preparation of heterocyclic compounds having anti-diabetic activity'1998 5,703,096'Oxime derivatives, their preparation and their therapeutic use'1997 5,688,823'Thiazolidine and oxazolidine derivatives their preparation and their medical use'1997 5,624,935'Heterocyclic compounds having anti-diabetic activity and their use'1997 5,616,599'Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use'1997 5,578,620'Thiazolidine and oxazolidine derivatives, their preparation and their medical use'1996 5,556,864'.alpha.-.omega.-diarylalkane compounds serotonin-2 receptor agonists'1996 5,002,942'1,5-benzothiazepine derivatives, their preparation and their use in the treatment of cardiovascular disorders'1991 4,791,196'Crystalline cephem carboxylic acid addition salt'1988 4,716,158'7-(2-amin othiazol-4-yl)-2-(syn)-methoxyiminoacetamido)-3-methoxymethyl-3-cepham-4- carboxylates'1987 4,486,425'7-[2-(2-A minothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem -4-carboxylates'1984 4,483,855'Cephalosporin derivative and antibiotic compositions'1984 4,482,710'Process for preparing 3-alkoxymethylcephalosporin derivatives'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–2006Patents assigned to SANKYO CO (23)· patent assignee history

1984Based in Hiromachi, JP· patent location history

1987–2000Based in Tokyo, JP· patent location history

1998–2006Based in Yokohama, JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
SANKYO CO	23	1984–2006

Locations

Location	Patents	Span
Tokyo, JP	17	1987–2000
Yokohama, JP	3	1998–2006
Hiromachi, JP	3	1984